Cerebras Systems, Inc. is a Sunnyvale, California-based designer of wafer-scale AI processors for training and inference that went public on the Nasdaq in May 2026. The company's analyst coverage is both broad and unusually optimistic. According to S&P Global data, 11 analysts carry a consensus "Strong Buy" rating, with seven at Strong Buy, three at Buy, and one at Hold.
The verified individual analyst price targets span $209 to $330. The arithmetic mean of those targets is approximately $292, which rounds to a clean central target of $290. Representative views include Mizuho's Vijay Rakesh at $300, Craig-Hallum's Richard Shannon at $325, UBS's Timothy Arcuri at $330, and a recently upgraded $209 target from Freedom Capital Markets. The spread between the lowest and highest targets is wide, reflecting genuine disagreement about how quickly the company can scale revenue and narrow its losses.
Cerebras Systems last closed at $149.09, leaving the shares well below their $386.34 all-time high and just above the 52-week low of $142.07. The company's market capitalization stands near $35 billion, with a price-to-sales ratio in the high double digits. Because reaching $290 from $149.09 requires a move of roughly 95%, the path to the target is very large by any standard and would likely require multiple quarters of accelerating revenue and a re-rating of the stock.
The company reported quarterly revenue of about $180 million for the period ended June 30, 2026, alongside a substantial GAAP net loss, and roughly $193 million in revenue the prior quarter. Trailing-twelve-month revenue sits near $680 million against a net loss of roughly $487 million. Put simply, the market is currently pricing in a growth story that has not yet produced sustained profitability.
The single largest support is the company's multi-year, roughly $20 billion contract with OpenAI to supply 750 megawatts of compute capacity, reinforced by a $1 billion loan from OpenAI and a public rebuttal from OpenAI CEO Sam Altman dismissing speculation about the relationship. Analysts such as Citigroup have indicated that their 2026–2028 revenue outlook for the company remains unchanged despite recent market chatter.
Beyond the anchor customer, Cerebras argues its wafer-scale engine delivers inference speeds far beyond GPU-based systems, positioning it for fast-growing AI inference workloads. Upcoming product launches, multi-year contracts, and a sector-wide surge in AI infrastructure spending provide further fuel for the bullish case.
The most prominent near-term overhang is the staggered expiration of IPO lockup provisions, which has released tens of millions of shares for potential sale. Insiders, including the CEO and CTO, have already sold hundreds of millions of dollars of stock under pre-arranged trading plans, adding supply pressure to an already weak tape.
The company also remains highly dependent on a small number of large customers, leaving it exposed if any single relationship shifts. A September report suggesting OpenAI's "Ultrafast" mode would run on NVIDIA GPUs rather than Cerebras hardware triggered a sharp selloff, underscoring this concentration risk. Competition from NVIDIA and other chipmakers, continued net losses, and a premium valuation all present objective obstacles to a 95% advance.
Cerebras Systems is in a clear downtrend, trading below its 50-day simple moving average near $197 and with a 14-day relative strength index near oversold territory. Durable support sits around $142–$146, the area of the 52-week low, with the psychological $150 level acting as nearby resistance. A meaningful recovery would first need to reclaim $160–$165, then the declining moving averages in the $190s. The $386 all-time high remains a distant reference point far above the current price.
Most analyst price targets reflect a research horizon of roughly 12 months, though individual firms vary. Investors should watch the next quarterly earnings release and revenue guidance, any changes to the OpenAI relationship, the pace of insider selling as lockups unwind, and analyst target revisions. Macroeconomic conditions, including interest-rate expectations, also matter for a high-multiple, unprofitable growth stock. None of these factors guarantees the shares will reach $290.
Tickeron's AI Daily Buy/Sell Signals uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis evolve. Traders can use the tool to discover new opportunities, monitor existing positions, and identify changing trends more efficiently than manual screening. For investors tracking volatile names like Cerebras Systems, these signals offer a practical way to stay oriented in fast-moving markets.
The $290 central target is derived from the arithmetic mean of 11 verified analyst price targets ranging from $209 to $330. From a price near $149, reaching it would require a very large move of roughly 95%, so the target should be read as an expression of long-term growth expectations rather than a near-term forecast. The bullish case rests on the OpenAI relationship and rapid AI infrastructure adoption, while the bearish case centers on customer concentration, competition from NVIDIA, lockup-related selling, and persistent losses. The wide analyst range underscores genuine uncertainty, and the shares will likely need sustained revenue acceleration and improving profitability to close the gap toward $290. No outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.